[Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003523:Cycloserine / Q000627:therapeutic use*; D005000:Ethionamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D011719:Pyrazines; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin
Possibilità e limiti del trattamento chemioantibiotico multiplo nella tubercolosi polmonare cronica.